1. Combination therapy for multidrug-resistant cytomegalovirus disease.
- Author
-
Stuehler C, Stüssi G, Halter J, Nowakowska J, Schibli A, Battegay M, Dirks J, Passweg J, Heim D, Rovo A, Kalberer C, Bucher C, Weisser M, Dumoulin A, Hirsch HH, and Khanna N
- Subjects
- Adoptive Transfer, Antiviral Agents therapeutic use, Combined Modality Therapy, Cytomegalovirus Infections immunology, Drug Therapy, Combination, Humans, Male, Middle Aged, Cytomegalovirus Infections therapy, Drug Resistance, Multiple, Viral, Hematopoietic Stem Cell Transplantation, Immunocompromised Host
- Abstract
Multidrug-resistant (MDR) cytomegalovirus (CMV) emerged after transient responses to ganciclovir, foscarnet, and cidofovir in a CMV-seropositive recipient who underwent allogeneic hematopoietic stem cell transplantation from a CMV-seronegative donor. Experimental treatments using leflunomide and artesunate failed. Re-transplantation from a CMV-seropositive donor supported by adoptive transfer of pp65-specific T cells and maribavir was followed by lasting suppression. This case illustrates that successful MDR CMV therapy may require individualized multidisciplinary approaches., (© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF